Cross-Border Innovation: Reshbha Munjal’s KorinMi Secures ₹10 Crore from Lotus Herbals to Expand Clinical Skincare Ecosystem
What is the news?
The convergence of global beauty standards and local demographic needs has marked a new milestone for India’s clinical wellness ecosystem. KorinMi, an advanced skin clinic startup co-founded by Indian entrepreneur Reshbha Munjal and Jenovia Daun Jung, has secured a strategic investment of ₹10 crore from Lotus Herbals’ $50 million Innovation Fund. Established in 2024, the startup has rapidly carved out a niche by blending highly sophisticated South Korean skin science with customized, clinical treatments specifically engineered for Indian skin phenotypes and environmental conditions.
Why is it interesting?
The fresh infusion of capital will primarily fuel KorinMi’s geographical expansion beyond its initial base in Gurugram, targeting rapid clinic rollouts in Tier-1 economic hubs including Mumbai, Bengaluru, and Hyderabad. Beyond expanding its brick-and-mortar footprint, which has already served over 3,000 clients, the company is scaling its specialized direct-to-consumer (D2C) product portfolio. These products are formulated and manufactured directly in South Korea, optimizing global supply chains to deliver premium solutions tailored to domestic climatic variables.
This funding round emphasizes a growing trend within the broader global founders community, where cross-border intellectual capital is leveraged to solve specific regional market challenges. Backed previously by angel investors like Vikas Agarwal, the former CEO of UAE-based Kaya Skin Clinic, KorinMi highlights how Indian-led enterprises are successfully institutionalizing international innovation assets, positioning the region as a high-value knowledge and consumer hub on the global stage.
Read more: Skin clinic KorinMi raises 10 Cr from Lotus Herbal’s Innovation Fund